Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00903968
Title Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute Boston Massachusetts 02115 United States Details
Cape Cod Hospital Hyannis Massachusetts 02601 United States Details
Milford Hospital Milford Massachusetts 01757 United States Details
Newton-Wellesley Hospital Newton Massachusetts 02462 United States Details
Cancer Treatment Centers of America (Eastern Regional Medical Center) Philadelphia Pennsylvania 19124 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field